Human Genome Epidemiology Literature Finder
|
Records 1 - 16 (of 16 Records) |
| Query Trace: Ovarian Neoplasms and MAF[original query] |
|---|
| Risk of contralateral breast cancer associated with common variants in BRCA1 and BRCA2: potential modifying effect of BRCA1/BRCA2 mutation carrier status. Breast cancer research and treatment 2010 Dec . Figueiredo JC, Brooks JD, Conti DV, Poynter JN, Teraoka SN, Malone KE, Bernstein L, Lee WD, Duggan DJ, Siniard A, Concannon P, Capanu M, Lynch CF, Olsen JH, Haile RW, Bernstein JL |
| BRCA2 variants and cardiovascular disease in a multi-ethnic study. BMC medical genetics 2012 13 56. Zbuk Kevin, Xie Changchun, Young Robin, Heydarpour Mahyar, Pare Guillaume, Davis A Darlene, Miller Ruby, Lanktree Matthew B, Saleheen Danish, Danesh John, Yusuf Salim, Engert James C, Hegele Robert A, Anand Sonia |
| Inherited common variants in mitochondrial DNA and invasive serous epithelial ovarian cancer risk. BMC research notes 2013 6 (1): 425. Earp Madalene A, Brooks-Wilson Angela, Cook Linda, Le N |
| No association between ovarian cancer susceptibility variants and breast cancer risk among Chinese women. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2013 Jan . Ma X, Cai Q, Delahanty R, Shu XO, Zhang B, Lu W, Gao YT, Zheng W, Long J, Beeghly-Fadiel A |
| Identification of Novel Breast Cancer Risk Loci. Cancer research 2017 Aug . Chan Claire Hian Tzer, Munusamy Prabhakaran, Loke Sau Yeen, Koh Geok Ling, Wong Edward Sern Yuen, Law Hai Yang, Yoon Chui Sheun, Tan Min-Han, Yap Yoon Sim, Ang Peter, Lee Ann Siew G |
| Screening of BRCA1/2 deep intronic regions by targeted gene sequencing identifies the first germline BRCA1 variant causing pseudoexon activation in a patient with breast/ovarian cancer. Journal of medical genetics 2018 11 56 (2): 63-74. Montalban Gemma, Bonache Sandra, Moles-Fernández Alejandro, Gisbert-Beamud Alexandra, Tenés Anna, Bach Vanessa, Carrasco Estela, López-Fernández Adrià, Stjepanovic Neda, Balmaña Judith, Diez Orland, Gutiérrez-Enríquez Sa |
| Prevalence of genetic susceptibility for breast and ovarian cancer in a non-cancer related study population: secondary germline findings from a Swiss single centre cohort. Swiss medical weekly 2019 Aug 149 w20092. Kraemer Dennis, Azzarello-Burri Silvia, Steindl Katharina, Boonsawat Paranchai, Zweier Markus, Dedes Konstantin J, Joset Pascal, Fink Daniel, Rauch Ani |
| Polymorphisms in MMP-14 and MMP-2 genes and ovarian cancer survival. Cancer biomarkers : section A of Disease markers 2019 Jun . Vos M Caroline, van Tilborg Angela, Brands William J, Boll Dorry, van Hamont Dennis, van der Putten Hans, Pijlman Brenda, van der Wurff Anneke A M, van Kuppevelt Toin H, Massuger Leon F A |
| Detecting TP53 mutations in diagnostic and archival liquid-based Pap samples from ovarian cancer patients using an ultra-sensitive ddPCR method. Scientific reports 2019 10 9 (1): 15506. Arildsen Nicolai Skovbjerg, Martin de la Fuente Laura, Måsbäck Anna, Malander Susanne, Forslund Ola, Kannisto Päivi, Hedenfalk Ingr |
| Assessing Genetic Variants in Matched Biocompartments From Patients With Serous Ovarian Cancer. Technology in cancer research & treatment 2021 6 20 15330338211027917. Sanders Brooke E, Ku Lisa, Walker Paul, Bitler Benjamin |
| Next Generation Sequencing-Based Germline Panel Testing for Breast and Ovarian Cancers in Pakistan. Asian Pacific journal of cancer prevention : APJCP 2021 3 22 (3): 719-724. Tariq Hassan, Gul Asma, Khadim Tahir, Ud-Din Hafeez, Tipu Hamid Nawaz, Asif Muhammad, Ahmed Rab |
| Novel candidates of pathogenic variants of the BRCA1 and BRCA2 genes from a dataset of 3,552 Japanese whole genomes (3.5KJPNv2). PloS one 2021 16 (1): e0236907. Tokunaga Hideki, Iida Keita, Hozawa Atsushi, Ogishima Soichi, Watanabe Yoh, Shigeta Shogo, Shimada Muneaki, Yamaguchi-Kabata Yumi, Tadaka Shu, Katsuoka Fumiki, Ito Shin, Kumada Kazuki, Hamanaka Yohei, Fuse Nobuo, Kinoshita Kengo, Yamamoto Masayuki, Yaegashi Nobuo, Yasuda J |
| Cell-free tumor DNA, CA125 and HE4 for the objective assessment of tumor burden in patients with advanced high-grade serous ovarian cancer. PloS one 2022 17 (2): e0262770. Heitz Florian, Lakis Sotirios, Harter Philipp, Heikaus Sebastian, Sehouli Jalid, Talwar Jatin, Menon Roopika, Ataseven Beyhan, Bertrand Miriam, Schneider Stephanie, Mariotti Erika, Bommert Mareike, Müller Judith N, Prader Sonia, Leenders Frauke, Hengsbach Alexandra, Gloeckner Christian, Braicu Elena Ioana, Heukamp Lukas C, du Bois Andreas, Heuckmann Johannes |
| Genetic variation in progesterone receptor gene and ovarian cancer risk: A case control study. Gene 2022 Feb 820 146288. Kanabekova Perizat, Al-Awadi Amina M, Bauyrzhanova Zhansaya, Tahtouh Tania, Sarray Sameh, Almawi Wassim |
| Integration of tumour sequencing and case-control data to assess pathogenicity of RAD51C missense variants in familial breast cancer. NPJ breast cancer 2022 1 8 (1): 10. Lim Belle W X, Li Na, Rowley Simone M, Thompson Ella R, McInerny Simone, Zethoven Magnus, Scott Rodney J, Devereux Lisa, Sloan Erica K, James Paul A, Campbell Ian |
| Improved detection of homologous recombination deficiency in Chinese patients with ovarian cancer: a novel non-exonic single-nucleotide polymorphism (SNP)-based next-generation sequencing (NGS) panel. Molecular oncology 2023 2 . Wei Bing, Zheng Jinxiang, Jiang Cai, Zhang He, Zhang Mingye, Cheng Taoran, Li Jun, Wang Zhizhong, Deng Lijun, Wang Li, Xia Qingxin, Ma J |
- Page last reviewed:Feb 1, 2024
- Content source: